Hartford Multifactor Emerging Markets ETF (ARCA: ROAM)

Latest News for Hartford Multifactor Emerging Markets ETF (ARCA:ROAM)

Hartford Multifactor Emerging Markets ETF

Lattice Emerging Markets Strategy ETF

Long Ideas

News

Broad U.S. Equity ETFs

Specialty ETFs

Emerging Market ETFs

Trading Ideas

ETFs

ROAM

RODM

ROGS

ROUS

LVUS

LVIN

Hartford Lowers Fees On 6 Smart Beta ETFs

REIT

Emerging Markets

New ETFs

Markets

Real Estate

RORE

SCHW

More ETF Fee Cuts, This Time From Hartford

Wherever I May ROAM: An Outperforming Emerging Markets ETF

WIIM

SIRI

Sirius XM Holdings shares are trading higher after Seaport Global upgraded the stock from Neutral to Buy and announced a $4.3 price target.

Welcome to a new episode of the Benzinga Psychedelics Podcast where we&#8217;re joined by Dr. Matthew X. Lowe, executive director and CSO to Unlimited Sciences, a Colorado-based nonprofit organization conducting and supporting research with psychedelics. Unlimited Sciences recently launched a toll-free "Psychedelic Info Line" to provide pre-psychedelic education and guidance. 
<figure class="wp-block-embed is-type-rich is-provider-spotify wp-block-embed-spotify wp-embed-aspect-21-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe title="Spotify Embed: Increased Destigmatization Of Psychedelics And A Rise In Educational Tools - The World Ahead By Dr. Matthew Lowe" style="border-radius: 12px" width="100%" height="152" frameborder="0" allowfullscreen allow="autoplay; clipboard-write; encrypted-media; fullscreen; picture-in-picture" loading="lazy" src="https://open.spotify.com/embed/episode/5wxnoCqDyHCOqRtOoMjtIo?si=71b4f8fe8e8849c7&#038;utm_source=oembed"></iframe>
</div>
</figure>
Listen to the podcast <a href="https://open.spotify.com/episode/5wxnoCqDyHCOqRtOoMjtIo?si=71b4f8fe8e8849c7">here</a>.
The line is already operational, taking calls worldwide . Even though its main focus is on the preparation side, it also provides tools for integration as requested by users. It welcomes those who are new to psychedelics as well as those with past experience. 
Psychedelics info line navigators are not necessarily experts but rather compassionate individuals who follow detailed scripts based on a variety of topics on psychedelics that were developed by numerous experts.
They are not there to opine or encourage the use of psychedelics nor give medical advice. In fact, the team encourages anyone aiming to begin using these substances to speak with their medical providers, healthcare team or physicians to ascertain whether psychedelics are right for them. 
Scripts and materials are built from a thorough review of published papers and other evidence-based sources on psychedelics, including the "largest naturalistic <a href="https://unlimitedsciences.org/worlds-largest-study-on-naturalistic-psilocybin-use-from-unlimited-sciences-reveals-lasting-therapeutic-benefits/">psilocybin study</a> in the world" (8,000+ individuals enrolled) designed jointly with researchers at Johns Hopkins University and other renowned institutions. 
"We do not want this to be an anecdotal or subjective or opinionated point of view. This is based on evidence that is out there in the field that we can utilize and share, and really translate from an academic context into a context that individuals can understand easily," explains Lowe. He added that the info line aims to provide the necessary information for people to make the decision to take psychedelics an informed one. 
Calls are confidential and don't require personal information. There's also an email service that works for those who want to further protect their identity, providing in-depth answers, educational resources and peer-reviewed evidence to make more informed decisions.
<h3 class="wp-block-heading">Rising Destigmatization To Be Matched With Education And Research Funding </h3>
The needs for the coming world where psychedelics will become increasingly available for use include education for providers as well as users.
"There's a lot of education that needs to be completed on administering psychedelics; and because of the 1971 scheduling, rescheduling of these substances, and the subsequent lack of research that was essentially halted over the following decades, there's not a lot of research still," Lowe says.&nbsp;
Unlimited Sciences' new info line inserts itself in the world of educational and harm reduction tools by providing pre-psychedelic information and education. It's neither a crisis hotline nor a support line for individuals currently taking psychedelics and experiencing challenges -much as <a href="https://www.benzinga.com/markets/cannabis/23/07/33399826/firesides-vision-expanding-support-beyond-harm-reduction-in-psychedelics">Fireside Project</a> or Zendo Project do.
"I think there's an ecosystem developing for both pre-psychedelic and post-psychedelic care that is really going to meld together, and I think it's a fantastic idea that these different resources support each other and provide information for various degrees of the different psychedelic experience," says Lowe.
As much as research is on the rise, there's still a lot to learn about regulations around training, education and administration of psychedelics as well as on the environments that support a successful psychedelic journey.
Lowe says the educational industry will rise to meet this challenge and the sector will grow exponentially. "What we know about psychedelics is changing so rapidly. And I think there is a need for training and certification for these individuals to administer psychedelics."
He also stresses the importance of funding research, which is not keeping up to pace with scientific and societal participation in psychedelics. Research into under-represented communities (<a href="https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1279887/full">see latest published research</a> on the long-term psychological health and wellbeing benefits after ceremonial use of ayahuasca in Middle Eastern and North African immigrants and refugees is particularly lacking.
Listen to the full episode on Spotify or wherever you get your podcasts by searching for &#8220;Benzinga Interviews.&#8221;
Photo courtesy of Unlimited Sciences.

Cannabis

Psychedelics

Education

Psychology

Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences

Intuitive Machines's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NYSE">LUNR</a>) short percent of float has risen 24.74% since its last report. The company recently reported that it has 3.77 million shares sold short, which is 49.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Intuitive Machines Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401024_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intuitive Machines has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Intuitive Machines's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Intuitive Machines's peer group average for short interest as a percentage of float is 8.89%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

LUNR

How Is The Market Feeling About Intuitive Machines?

Macro Economic Events

Econ #s

Economics

Dallas Fed Mfg Business Index For April -14.5 Vs -14.4 Prior

Meta Data's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIU#NYSE">AIU</a>) short percent of float has fallen 40.0% since its last report. The company recently reported that it has 24 thousand shares sold short, which is 0.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Meta Data Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401018_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Meta Data has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Meta Data's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Meta Data's peer group average for short interest as a percentage of float is 2.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Meta Data's Recent Short Interest

PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) has outperformed the market over the past 5 years by 7.43% on an annualized basis producing an average annual return of 19.08%. Currently, PACCAR has a market capitalization of $59.74 billion. 
Buying $1000 In PCAR: If an investor had bought $1000 of PCAR stock 5 years ago, it would be worth $2,435.39 today based on a price of $114.00 for PCAR at the time of writing.
<h3>PACCAR's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401018_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PCAR

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today

BlackRock's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) short percent of float has risen 3.33% since its last report. The company recently reported that it has 1.82 million shares sold short, which is 1.24% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BlackRock Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401013_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BlackRock has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing BlackRock's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BlackRock's peer group average for short interest as a percentage of float is 2.75%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About BlackRock?

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 15 years by 12.83% on an annualized basis producing an average annual return of 25.05%. Currently, Copart has a market capitalization of $53.67 billion. 
Buying $1000 In CPRT: If an investor had bought $1000 of CPRT stock 15 years ago, it would be worth $28,380.04 today based on a price of $55.82 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401013_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CPRT

Here's How Much $1000 Invested In Copart 15 Years Ago Would Be Worth Today

Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), will be reporting its first-quarter earnings on Tuesday. Wall Street expects 78 cents in EPS and $133.1 billion in revenues as the company reports <a href="https://www.benzinga.com/calendars/earnings?tickers=AMZN">after market hours</a>.
Amazon stock has been buoyed by the company&#8217;s strong positioning in AI, cloud computing, and e-commerce. The stock has been on an upward trajectory, gaining 71.10% over the past year and showing a positive trend of 18.22% YTD.
<h2 class="wp-block-heading">Key Factors To Watch As Amazon Reports Q1 Earnings</h2>
As Amazon prepares to report its Q1 earnings, investors are keenly watching several key factors.
<ul>
<li>The performance of Amazon Web Services (AWS) and its progress in AI development.</li>
<li>Market-share gains in digital advertising</li>
<li>The impact of recent price increases on third-party sellers&#8217; results</li>
</ul>
These will be significant indicators of Amazon&#8217;s growth potential.
One of the primary focuses for investors is profitability. Amazon&#8217;s efforts to improve margins and operational efficiency will be closely monitored, especially as the company aims to become more efficient and profitable in 2024.
Amazon&#8217;s strategic investments in robotic automation in warehouses are also worth noting. With over 750,000 robots deployed, Amazon is aiming to reduce fulfilment costs and increase efficiency. This automation drive has already shown results, with fulfilment costs growing less than overall revenue, indicating potential significant cost savings in the future.
Also Read: <a href="https://www.benzinga.com/government/24/04/38437731/amazons-aws-mega-investment-marks-indianas-biggest-capital-infusion-ever">Amazon&#8217;s AWS Mega Investment Marks Indiana&#8217;s Biggest Capital Infusion Ever</a>
<h2 class="wp-block-heading">Charts Indicates A Bullish Resurgence For Amazon Stock</h2>
From a technical analysis perspective, Amazon&#8217;s stock is currently experiencing a bullish resurgence with slight buying pressure. 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="625" height="454" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/29084616/Screenshot-2024-04-29-at-6.15.48-PM.png" alt="" class="wp-image-313157" style="width:800px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/29084616/Screenshot-2024-04-29-at-6.15.48-PM.png 625w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/29084616/Screenshot-2024-04-29-at-6.15.48-PM-300x218.png 300w" sizes="(max-width: 625px) 100vw, 625px" /></figure>
<a target="_blank" href="https://pro.benzinga.com/dashboard" rel="noreferrer noopener">Chart: Benzinga Pro</a>
Amazon stock&#8217;s price is trading above its key short-term moving averages, reflecting positive market momentum. The 8-day simple moving average (SMA) stands at $177.84, signaling a bullish trend. Further, the 20-day SMA at $181.55, and the 50-day SMA at $178.03, reinforce the bullish trend.
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="625" height="454" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/29084803/Screenshot-2024-04-29-at-6.14.45-PM.png" alt="" class="wp-image-313159" style="width:800px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/29084803/Screenshot-2024-04-29-at-6.14.45-PM.png 625w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/29084803/Screenshot-2024-04-29-at-6.14.45-PM-300x218.png 300w" sizes="(max-width: 625px) 100vw, 625px" /></figure>
<a target="_blank" href="https://pro.benzinga.com/dashboard" rel="noreferrer noopener">Chart: Benzinga Pro</a>
The Moving Average Convergence Divergence (MACD) indicator is 0.05, suggesting a moderately bullish signal. The Relative Strength Index (RSI) is in the Neutral zone at 54.37, a long way off being either oversold or overbought. 
The Bollinger Bands for Amazon stock are suggesting a bullish trend. The stock&#8217;s price line has just crossed over from the lower band to the upper band ahead of Q1 earnings, reflective of positive sentiments driving the stock.
<h2 class="wp-block-heading">Wall Street Analysts See 17% Upside</h2>
Amazon&#8217;s stock has shown strong performance and strategic positioning in key areas. The technical analysis shows a resurgence in bullish sentiments right ahead of the company&#8217;s Q1 earnings announcement. 
Moving averages and oscillators both point towards a positive near-term stock trajectory for Amazon stock. Further, fundamental factors provide strength to the longer-term thesis.
Per <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">Wall Street analyst consensus</a>, Amazon stock is a Buy with an implied 17% upside per recent analyst reports.
The overall outlook for Amazon remains positive, especially with its continued focus on profitability and efficiency improvements.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38439724/whats-in-the-cards-for-amazon-in-q1-analyst-sees-double-digit-sales-and-profit-grow">What&#8217;s In The Cards For Amazon In Q1? Analyst Sees Double-Digit Sales And Profit Growth</a>
Photo: Shutterstock

Earnings

Technicals

Tech

AMZN

Amazon's Chart Offers Clues Before Tuesday's Q1 Earnings Reveal

GERN

Geron Corporation shares are trading higher after TD Cowen initiated coverage on the stock with a Buy rating and a $10 price target.

Franklin Resources shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results.

TNDM

Tandem Diabetes Care shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight and raised its price target from $21 to $45.

Laboratory Corporation Of America Holdings

Labcorp shares are trading higher after the company announced that the FDA approved its nABCyte Anti-AAVRh74var HB-FE Assay, a companion diagnostic, to determine patient eligibility for treatment with BEQVEZ.

The U.S. Department of Justice reportedly concluded an investigation into luxury vehicle maker&nbsp;Mercedes-Benz Group AG&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MBGYY#OTC">MBGYY</a>)&nbsp;related to exhaust emissions without filing charges against the German automaker.
The Stuttgart-based company confirmed the closure of the investigation on Saturday, reported&nbsp;<a target="_blank" href="https://www.bloomberg.com/news/articles/2024-04-27/mercedes-says-doj-ended-diesel-probe-without-filing-charges?srnd=homepage-americas&amp;sref=TBDibEcD" rel="noreferrer noopener">Bloomberg</a>.
The decision marks a significant development in the legal landscape surrounding diesel-related issues.
Renata Jungo Bruengger, a member of Mercedes-Benz&#8217;s management board, reportedly emphasized the decision as a crucial milestone toward legal clarity regarding various diesel-related matters.
However, officials from the DOJ refrained from immediate comments, as per the report.
In April 2016, Mercedes-Benz witnessed a notable decline in its shares following the disclosure of the DOJ&#8217;s inquiry into its certification and admissions procedures concerning exhaust emissions in the U.S.
Mercedes Benz stock has gained over 2% in the last 12 months.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38113676/mercedes-alabama-workers-gear-up-for-uaw-union-election-report" rel="noreferrer noopener">Mercedes Alabama Workers Gear Up For UAW Union Election: Report</a>
Price Action: MBGYY shares traded higher by 1.22% at $19.84 at last check Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo by pisaphotography on Shutterstock

Equities

Legal

Media

General

MERCEDES-BENZ UNSP / ADR by Mercedes Benz Group AG

MBGYY

Justice Department Spares Mercedes-Benz: US Emission Probe Reportedly Closed

PTCT

PTC Therapeutics shares are trading higher after Morgan Stanley upgraded the stock from Underweight to Equal-Weight and raised its price target from $28 to $30.

<a href="https://twitter.com/CitronResearch/status/1784951019451134030">https://twitter.com/CitronResearch/status/1784951019451134030</a>

Analyst Ratings

BIDU

TSLA

CitronResearch Posts On X "$BIDU First Step To $180. This $TSLA Partnership Is Small Part Of A Much Larger Story. $BIDU Is Still The Leader In: Search, AI, And What Citron Most Excited About Comate, The Future Of Programming Business Software In China. Also The $TSLA News Overshadowed The Partnership…"

Barrington Research analyst Vincent Colicchio maintains Perficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFT#NASDAQ">PRFT</a>) with a Outperform and maintains $77 price target.

Price Target

PRFT

Barrington Research Maintains Outperform on Perficient, Maintains $77 Price Target

Barrington Research analyst Gary Prestopino maintains Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) with a Outperform and maintains $360 price target.

Barrington Research Maintains Outperform on Kadant, Maintains $360 Price Target

Biotech

J&J Says CHMP Recommends Conversion Of Conditional Marketing Authorization For Sirturo (Bedaquiline) Into Standard Marketing Authorization

Barrington Research analyst Vincent Colicchio maintains Asure Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASUR#NASDAQ">ASUR</a>) with a Outperform and maintains $17 price target.

ASUR

Barrington Research Maintains Outperform on Asure Software, Maintains $17 Price Target

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Hartford Multifactor Emerging Markets ETF (ARCA:ROAM)

Tuesday, March 13, 2018

Thursday, December 15, 2016

Monday, March 28, 2016